Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: UK Health Minister Refuses To Rule Out 3rd England Lockdown

Mon, 04th Jan 2021 09:52

(Alliance News) - UK Health Secretary Matt Hancock has refused to rule out another national lockdown in England amid concerns the new variant coronavirus is spreading out of control.

Hancock hailed the start of the rollout of the Oxford University and AstraZeneca PLC vaccine as an 82-year-old former maintenance manager became the first person to receive the jab outside of clinical trials.

He said the NHS had the capacity to deliver two million doses a week of the vaccine once it received supplies from the manufacturers.

But with the latest data showing a 33% rise in the number of confirmed coronavirus patients in hospital in England between Christmas Day and January 2, he warned there would be "some very difficult weeks" to come.

Asked about the prospect of another national lockdown, he acknowledged that the current restrictions were insufficient to control the spread of the disease.

He told Sky News: "We don't rule anything out, and we've shown repeatedly that we will look at the public health advice and we will take the public health advice in terms of what is needed to control the spread of the disease.

"This new variant is much easier to catch, it is much more transmissible, and we're now seeing the effect of that in lots of different parts of the country, unfortunately.

"And it means that whereas the old Tier 3 was able to contain the old variant, that is proving increasingly difficult in all parts of the country."

His warning came as the Scottish Parliament was being recalled to consider further restrictions following a rapid increase in cases there.

Despite the concerns, Hancock insisted it was safe for primary schools to reopen in all but the worst hit areas of England following the Christmas break.

He said that teachers were at no greater risk of contracting the disease than the rest of the population.

"There is clear public health advice behind the position that we have taken and that is what people should follow because, of course, education is very important as well, especially for people's long-term health," he said.

However, UK Prime Minister Boris Johnson is coming under pressure from unions in the education sector to order a "pause" in a return to the classroom until the safety of staff and pupils can be guaranteed.

In a joint statement, the GMB, NAHT, NASUWT, NEU, Unison and Unite unions said there was a "serious risk" of staff falling ill while the rate of infection was so high.

"The government's chaotic handling of the opening of schools has caused confusion for teachers, school staff and parents alike," they said.

"Bringing all pupils back into classrooms while the rate of infection is so high is exposing education sector workers to serious risk of ill-health and could fuel the pandemic."

For Labour, shadow education secretary Kate Green said there needed to be a "stronger set" of coronavirus restrictions in place with a clear "stay at home" message to the public.

She told BBC Radio 4's Today programme: "It is very clear that the government has lost control of the virus, we're seeing a really alarming rise in cases and in the spread of the infection."

By Gavin Cordon and Emma Bowden, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.